Wegovy (Semaglutide) for Weight Management in Singapore

Medically reviewed by Dr Michael Ross MacDonald – The Harley Street Heart & Vascular Centre. Last reviewed: August 2026

Key Facts

  • Wegovy (semaglutide) is the version dosed for weight management; in Singapore obesity has risen to 12.7% of adults aged 18–74 (MOH National Population Health Survey 2024).
  • In the STEP 1 trial, semaglutide 2.4 mg produced an average body-weight reduction of about 15% over 68 weeks; weight may return if treatment and lifestyle measures stop.
  • Trial figures are averages - individual results vary.

Overview

Wegovy is a brand name for semaglutide, a once-weekly injectable GLP-1 receptor agonist. It is the version of semaglutide dosed for weight management in eligible adults, used alongside a reduced-calorie diet and increased physical activity. It is a prescription-only medicine, which means it can only be supplied after a doctor has assessed your suitability.

In Singapore, interest in medicines that support weight management has grown, and Wegovy is one option a doctor may discuss with you. It is not a standalone solution and is not intended to replace the everyday habits that influence weight, such as eating patterns, activity levels, sleep and stress. Instead, it is intended to be used within a structured plan that you and your doctor agree on, with regular review.

Wegovy vs Ozempic

Wegovy and Ozempic contain the same active ingredient (semaglutide) but are dosed and registered for different purposes - Wegovy for weight management, Ozempic for type 2 diabetes. They are not interchangeable. The maximum maintenance doses and the licensed indications differ, and a product registered for one purpose should not be substituted for the other without medical guidance.

Because the two products share an active ingredient, they are sometimes confused in everyday conversation and online. It is helpful to remember that the registered indication, dosing schedule and clinical monitoring may differ. Your doctor can explain which product, if any, is appropriate for your situation. You can read more in our notes on Ozempic and the wider class of GLP-1 Medicines.

Why it's used

  • To support weight management in adults who meet clinical criteria (for example, based on body mass index (BMI) and related health conditions)
  • As part of a wider plan including nutrition, physical activity and behaviour change
  • To support, rather than replace, sustained lifestyle change over time

Wegovy is generally considered when lifestyle measures alone have not achieved or maintained a clinically meaningful change, and when a doctor judges that the potential benefits may outweigh the risks for that individual. The aim of weight management is not appearance alone; it is often to reduce the burden of weight-related health conditions such as high blood pressure, abnormal blood lipids, joint strain and disturbed blood glucose. Your doctor will explain the goals that are relevant to you.

How it works

  • Slows stomach emptying, so you feel full for longer after meals
  • Acts on appetite centres in the brain to reduce hunger and food preoccupation
  • Also affects blood glucose regulation via insulin and glucagon

Semaglutide mimics a naturally occurring hormone called GLP-1, which the body releases after eating. By acting on the same pathways, it can reduce appetite and help some people eat less without feeling as deprived. These effects tend to build up gradually as the dose is increased, rather than appearing all at once. Individual responses vary, and the medicine works well when paired with consistent changes to diet and activity.

Who may be suitable

Wegovy is for eligible adults assessed by a doctor - it is not suitable for everyone seeking weight loss, and eligibility depends on clinical criteria, not appearance goals alone. Suitability is usually considered in relation to BMI thresholds, often together with the presence of weight-related health conditions. Your doctor will take a full history, review your other medicines and consider your overall health before deciding whether Wegovy may be appropriate.

It is generally not used in pregnancy or while trying to conceive, and your doctor will discuss contraception and family planning where relevant. People with certain medical or psychological conditions, or a history of particular illnesses, may not be suitable. The decision is individual and made with your doctor.

The role of diet and activity

Wegovy is licensed for use alongside a reduced-calorie diet and increased physical activity, not as a substitute for them. The medicine may make it easier to eat less, but the quality of what you eat still matters for nutrition, energy and long-term health.

  • Nutrition: A balanced eating pattern with adequate protein can help protect muscle while weight reduces. A dietitian or your doctor can offer practical guidance suited to local foods and eating habits.
  • Activity: Regular movement, including some resistance exercise, supports overall health and can help maintain muscle and bone strength.
  • Behaviour change: Sleep, stress management, meal timing and mindful eating all play a part. These habits remain important during treatment and if treatment later stops.

Building these habits while on the medicine gives you a foundation to fall back on, which matters because the appetite effects of the medicine fade once it is stopped.

Risks and side effects

  • Common: nausea, vomiting, diarrhoea, constipation, reduced appetite
  • Less common: gallbladder problems, pancreatitis
  • Not suitable with a personal or family history of medullary thyroid carcinoma or MEN2 syndrome

Gastrointestinal effects such as nausea are among the more frequently reported, and they often ease as the body adjusts and as the dose is increased slowly. Staying hydrated, eating smaller meals and avoiding very rich or fatty foods can help some people manage these effects. Dehydration from vomiting or diarrhoea can occasionally affect kidney function, so it is important to tell your doctor if symptoms are severe or persistent.

You should seek medical advice promptly for severe or persistent abdominal pain, signs of a gallbladder problem, an allergic reaction, or any symptom that worries you. This list is not exhaustive; your doctor or pharmacist can provide the full product information and explain what to watch for.

Before you start

A consultation confirms eligibility, screens for contraindications and sets up monitoring and review. Your doctor will review your medical history, current medicines and any previous experiences with weight management. This is also an opportunity to discuss your goals, expectations and any concerns.

Wegovy should never be self-sourced, bought from unverified suppliers or shared with others. Medicines obtained outside proper channels may be counterfeit, incorrectly stored or unsuitable for you, and using them without medical oversight can be unsafe. Supply through a doctor allows for appropriate assessment, dosing and follow-up.

What to expect

The dose is increased step by step, usually over a period of weeks, to limit side effects and help your body adjust. Ongoing review supports safe progress alongside lifestyle changes, and your doctor may adjust the plan based on how you respond and tolerate the medicine.

At follow-up visits, your doctor may check on side effects, review your progress and discuss your diet and activity. Monitoring is part of safe use; it allows the plan to be tailored over time. The injection is typically given under the skin once a week, and your doctor or nurse can show you how to use the device and store it correctly.

Results

Weight changes vary between individuals and depend on continued lifestyle measures. Any figures should reflect published trial averages rather than promises for any one person; trials have shown that semaglutide used for weight management, alongside lifestyle measures, can support reduction in body weight in many participants. Results are not guaranteed, and individual outcomes differ.

It is also important to understand that weight may return if treatment and lifestyle measures stop. This is common to many weight-management approaches and reflects the fact that the underlying biology that regulates weight does not disappear. For this reason, your doctor will usually frame treatment as part of a longer-term plan rather than a short course.

What to discuss with your doctor

  • Your full medical history, including any thyroid, pancreatic, gallbladder or mental-health conditions
  • All other medicines and supplements you take, as some may interact
  • Plans for pregnancy or breastfeeding
  • Realistic, individual goals and how progress will be reviewed
  • What to do if you experience side effects or miss a dose
  • How long treatment might continue, and what happens if it stops

Wegovy is a prescription-only medicine. The information here is general and educational, and does not replace personalised advice from your doctor.

Frequently Asked Questions

Is Wegovy the same as Ozempic?

Same medicine (semaglutide), different dosing and registered use - Wegovy for weight, Ozempic for diabetes. They are not interchangeable.

Do I keep the weight off after stopping Wegovy?

Weight can return if treatment stops, which is why long-term lifestyle measures and review matter. Your doctor can discuss what stopping might mean for you.

How is Wegovy taken?

As a once-weekly injection under the skin, with the dose increased gradually to help limit side effects.

Can I take Wegovy just to lose a little weight for appearance?

Wegovy is intended for eligible adults who meet clinical criteria, not for cosmetic weight loss alone. Your doctor will assess whether it is appropriate for you.

How long will I need to take it?

This varies between individuals. Weight management is often a long-term process, and your doctor will discuss the expected duration and review points with you.

What happens if I miss a dose?

Your doctor or pharmacist will advise you on what to do, as this can depend on how long it has been since your last dose. Do not double up doses without guidance.

Related reading: GLP-1 Medicines; Ozempic; Mounjaro

Medical Resources & References

  • Cleveland Clinic - GLP-1 agonists - https://my.clevelandclinic.org/health/treatments/13901-glp-1-agonists
  • MOH - National Population Health Survey 2024 - https://www.moh.gov.sg/others/resources-and-statistics/national-population-health-survey–nphs–2024-report/